Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Vitamin D Signaling Pathways Confer the Susceptibility of Esophageal Squamous Cell Carcinoma in a Northern Chinese Population.

Yang J, Wang H, Ji A, Ma L, Wang J, Lian C, Wei Z, Wang L.

Nutr Cancer. 2017 May-Jun;69(4):593-600. doi: 10.1080/01635581.2017.1299873. Epub 2017 Mar 31.

PMID:
28362172
2.

Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.

Hsieh CC, Hsu HS, Chang SC, Chen YJ.

Int J Mol Sci. 2016 Dec 17;17(12). pii: E2131. doi: 10.3390/ijms17122131.

3.

[Clinical implications of the concentration and EGFR/KRAS mutations of plasma cell free DNA of patients with lung cancer and esophageal cancer].

Zhang R, Li Y, Chen Y, Liu X, Wang Z, Sun H, Zheng Y, Ding Z, Lan L, Li M, Qin J, Chen X.

Zhonghua Yi Xue Za Zhi. 2015 Dec 15;95(47):3839-42. Chinese.

PMID:
27337801
4.

Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma.

Luo H, Li H, Hu Z, Wu H, Liu C, Li Y, Zhang X, Lin P, Hou Q, Ding G, Wang Y, Li S, Wei D, Qiu F, Li Y, Wu S.

Biochem Biophys Res Commun. 2016 Mar 18;471(4):596-602. doi: 10.1016/j.bbrc.2016.02.011. Epub 2016 Feb 12.

PMID:
26876573
5.

Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.

Li X, Zhou F, Jiang C, Wang Y, Lu Y, Yang F, Wang N, Yang H, Zheng Y, Zhang J.

PLoS One. 2014 Jul 22;9(7):e103162. doi: 10.1371/journal.pone.0103162. eCollection 2014.

6.

Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones).

Damelin LH, Jivan R, Veale RB, Rousseau AL, Mavri-Damelin D.

BMC Cancer. 2014 May 5;14:314. doi: 10.1186/1471-2407-14-314.

7.

Clinical impact of predicting CCND1 amplification using plasma DNA in superficial esophageal squamous cell carcinoma.

Komatsu S, Ichikawa D, Hirajima S, Takeshita H, Shiozaki A, Fujiwara H, Kawaguchi T, Miyamae M, Konishi H, Kubota T, Okamoto K, Yagi N, Otsuji E.

Dig Dis Sci. 2014 Jun;59(6):1152-9. doi: 10.1007/s10620-013-3005-2. Epub 2014 Jan 24.

PMID:
24458211
8.

Clinical significance of combined detection of human papilloma virus infection and human telomerase RNA component gene amplification in patients with squamous cell carcinoma of the esophagus in northern China.

Wang YF, Wang XS, Gao SG, Chen Q, Yang YT, Xiao ZY, Peng XQ, Hu XF, Wang QY, Feng XS.

Eur J Med Res. 2013 May 1;18:11. doi: 10.1186/2047-783X-18-11.

9.

[Effect of vitamin E and selenium deficiency on esophageal tumorigenesis and its oxidative stress mechanism].

Yang H, Li Y, Fang J, Jia X, Li N.

Wei Sheng Yan Jiu. 2013 Jan;42(1):23-30. Chinese.

PMID:
23596703
10.

Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.

Takata Y, Kristal AR, Santella RM, King IB, Duggan DJ, Lampe JW, Rayman MP, Blount PL, Reid BJ, Vaughan TL, Peters U.

PLoS One. 2012;7(6):e38612. doi: 10.1371/journal.pone.0038612. Epub 2012 Jun 8.

11.

Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma.

Shoji M, Ninomiya I, Makino I, Kinoshita J, Nakamura K, Oyama K, Nakagawara H, Fujita H, Tajima H, Takamura H, Kitagawa H, Fushida S, Harada S, Fujimura T, Ohta T.

Int J Oncol. 2012 Jun;40(6):2140-6. doi: 10.3892/ijo.2012.1416. Epub 2012 Mar 26.

PMID:
22469995
12.

[Studies on tea and health].

Han C.

Wei Sheng Yan Jiu. 2011 Nov;40(6):802-5. Review. Chinese.

PMID:
22279681
13.

MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma.

Ling ZQ, Zhao Q, Zhou SL, Mao WM.

Eur J Surg Oncol. 2012 Apr;38(4):326-32. doi: 10.1016/j.ejso.2012.01.008. Epub 2012 Jan 23.

PMID:
22265839
14.

Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma.

Liu JB, Qiang FL, Dong J, Cai J, Zhou SH, Shi MX, Chen KP, Hu ZB.

World J Gastroenterol. 2011 Nov 28;17(44):4917-21. doi: 10.3748/wjg.v17.i44.4917.

15.

[Cisplatin induces drug resistance in human esophageal squamous carcinoma cell line EC109 by decreasing CTR1 protein expression].

Yu L, Chen MH, Gu CP, Li YL, Wen J, Fu JH, Cho CH, Liu SW.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):801-4. Chinese.

16.

Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.

Andolfo I, Petrosino G, Vecchione L, De Antonellis P, Capasso M, Montanaro D, Gemei M, Troncone G, Iolascon A, Orditura M, Ciardiello F, De Vita F, Zollo M.

BMC Cancer. 2011 Apr 11;11:126. doi: 10.1186/1471-2407-11-126.

17.

Recent patents of DNA methylation biomarkers in gastrointestinal oncology.

Corvalan AH, Maturana MJ.

Recent Pat DNA Gene Seq. 2010 Nov;4(3):202-9. Review.

PMID:
21073436
18.

Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.

Zhang Y, Miao Y, Yi J, Wang R, Chen L.

Clin Lung Cancer. 2010 Jul 1;11(4):264-70. doi: 10.3816/CLC.2010.n.034.

PMID:
20630829
19.

Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls.

Zacho J, Yazdanyar S, Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG.

Int J Cancer. 2011 Feb 1;128(3):644-52. doi: 10.1002/ijc.25375.

20.

Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma.

Takeshita H, Ichikawa D, Komatsu S, Tsujiura M, Kosuga T, Deguchi K, Konishi H, Morimura R, Shiozaki A, Fujiwara H, Okamoto K, Otsuji E.

Br J Cancer. 2010 Apr 27;102(9):1378-83. doi: 10.1038/sj.bjc.6605657. Epub 2010 Apr 13.

Supplemental Content

Loading ...
Support Center